Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
A dog found on top of England's highest mountain has been reunited with his owner.
Cooler in the north, feeling close further south as moisture and heat build up
The first British boxer to win an Olympic gold medal beat Andre Dirrell in Boston last night to fight his way into the history books.